Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrien Inoubli

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Drug Safety|October 30, 2020
Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)Priya Bahri, Daniel R Morales, Adrien Inoubli, et al.
The Journal of Sexual Medicine|December 1, 2010
Karyotyping, is it worthwhile in transsexualism?Adrien Inoubli, Griet De Cuypere, Robert Rubens, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Drug Safety|October 30, 2020
Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)Priya Bahri, Daniel R Morales, Adrien Inoubli, et al.
The Journal of Sexual Medicine|December 1, 2010
Karyotyping, is it worthwhile in transsexualism?Adrien Inoubli, Griet De Cuypere, Robert Rubens, et al.
Pageof 1